Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/11/2012US20120258166 Rifaximin compositions and method of use
10/11/2012US20120258164 Transdermal granisetron
10/11/2012US20120258163 Tyrosine Kinase Microspheres
10/11/2012US20120258162 Controlled delivery of molecules from a biointerface
10/11/2012US20120258161 Implantable polymeric device for sustained release of dopamine agonist
10/11/2012US20120258159 Malleable, biodegradable hemostatic agent
10/11/2012US20120258148 Endosseous implant
10/11/2012US20120258144 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
10/11/2012US20120258143 Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
10/11/2012US20120258141 Methods Of Immune Modulation
10/11/2012US20120258140 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
10/11/2012US20120258133 Construct
10/11/2012US20120258125 Method to identify a novel class of immunologic adjuvants
10/11/2012US20120258123 Biomarkers for sensitive detection of statin-induced muscle toxicity
10/11/2012US20120258120 Compositions and methods for the systemic treatment of arthritis
10/11/2012US20120258117 Methods and compositions for modulation of histone ubiquitination
10/11/2012US20120258116 Method for inducing cancer cell apoptosis or inhibiting the cancer cell migration
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258100 Chimeric anti-ricin antibody
10/11/2012US20120258099 Inhibitors of guanine exchange factors and their use as anticancer drugs
10/11/2012US20120258093 Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
10/11/2012US20120258087 Isotonic beverage with chelates
10/11/2012US20120258081 Methods of treating proliferative diseases
10/11/2012US20120258080 Pyridopyrazine derivatives and their use
10/11/2012US20120258079 Treatment and Prevention of Dengue Virus Infections
10/11/2012US20120258078 Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis c
10/11/2012US20120258076 Method for characterizing host immune funtion by ex vivo induction of offensive and defensive immune markers
10/11/2012US20120258064 Substantially anhydrous compositions for personal care
10/11/2012US20120258062 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
10/11/2012US20120258061 Method for Treating Skin with Retinoids and Retinoid Boosters
10/11/2012US20120258060 Methods for protecting the skin from radiation insults
10/11/2012US20120258058 Formulation with irritation reducing action comprising bisabolol and [6]-paradol
10/11/2012US20120258056 Treatment of cancer and compositions
10/11/2012US20120258046 Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
10/11/2012US20120258045 Inhibitors and methods of treatment of cardiovascular diseases, and methods for identifying inhibitors
10/11/2012US20120258043 Linkable Lewis X Analogs
10/11/2012US20120258042 Combined use of tgf-b signaling inhibitor and antitumor agent
10/11/2012US20120255544 Bepotastine compositions
10/11/2012US20120255502 Package and method of marketing
10/11/2012DE102012003714B3 Detecting natural or synthetic, proliferative cells, genetically programmed or de novo programmed, useful for functioning as input-output transformation imitating reproductive organ activity, comprises e.g. carrying out cellular reaction
10/11/2012DE102011006974A1 New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, ischemia and vascular disease
10/11/2012DE102010051391A1 New lisuride, terguride or 1,1-diethyl-3-(R)-4,6,6a,7,8,9,10,10a-octa hydro-indolo(4,3-fg)quinolin-9-yl-urea derivative, is 5-hydroxytryptamine 2A receptor antagonist, useful to treat and/or prevent pulmonary arterial hypertension
10/11/2012CA2838109A1 Methods and compositions for treating raynaud's disease
10/11/2012CA2834871A1 Composition comprising antimicrobial metal ions and a quaternary cationic surfactant
10/11/2012CA2832818A1 Anti-viral combination therapy
10/11/2012CA2832783A1 Zinc n-acetyl taurinate for the treatment of prostate cancer
10/11/2012CA2832685A1 Pyrimidine derivatives for the treatment of viral infections
10/11/2012CA2832598A1 Selective androgen receptor modulators for treating diabetes
10/11/2012CA2832500A1 Pharmaceutical composition comprising fesoterodine
10/11/2012CA2832483A1 Methods and compositions for treating neurodegenerative diseases
10/11/2012CA2832439A1 Migrastatins and uses thereof
10/11/2012CA2832422A1 Epoxyeicosatrienoic acid analogs and methods of making and using the same
10/11/2012CA2832374A1 Imidazopyridazines as akt kinase inhibitors
10/11/2012CA2832337A1 Pyridopyrazine derivatives and their use
10/11/2012CA2832324A1 Methods of treating central nervous system tumors
10/11/2012CA2832321A1 Pyridopyrazine derivatives and their use
10/11/2012CA2832310A1 Substituted imidazopyridines and intermediates thereof
10/11/2012CA2832306A1 Treatment regimens
10/11/2012CA2832303A1 Pharmaceutical preparation
10/11/2012CA2832291A1 Pyrrolo[2,3-d)pyrimidine tropomyosin-related kinase inhibitors
10/11/2012CA2832286A1 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes
10/11/2012CA2832273A1 Synergistic compositions and methods
10/11/2012CA2832157A1 Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
10/11/2012CA2832130A1 Pharmaceutical composition
10/11/2012CA2832123A1 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
10/11/2012CA2832120A1 Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines
10/11/2012CA2832100A1 Aminopyrazine compounds useful as inhibitors of tra kinase
10/11/2012CA2831995A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
10/11/2012CA2831987A1 Method for the preparation of process intermediates for the synthesis of argatroban monohydrate
10/11/2012CA2831853A1 Special fluid composition and use thereof
10/11/2012CA2831843A1 Protein kinase inhibitors
10/11/2012CA2831813A1 Protein kinase inhibitors
10/11/2012CA2831697A1 Process for the preparation of a sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine
10/11/2012CA2831474A1 New indolinone protein kinase inhibitors
10/11/2012CA2831342A1 Medicament for liver regeneration and for treatment of liver failure
10/11/2012CA2831334A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
10/11/2012CA2830958A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods
10/11/2012CA2830920A1 Isoxazole derivatives useful as antibacterial agents
10/11/2012CA2830866A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
10/11/2012CA2830845A1 Solid state forms of hiv inhibitor
10/11/2012CA2830626A1 Method for treating asthenopia
10/11/2012CA2830581A1 Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
10/11/2012CA2830463A1 Crystalline and non-crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer
10/11/2012CA2830367A1 Novel imidazo-oxazine compound or salt thereof
10/11/2012CA2830045A1 Healing composition for topical application
10/11/2012CA2830028A1 Sn-1(3) monoacylglycerides and lipid absorption
10/11/2012CA2829181A1 The treatment of viral infections
10/11/2012CA2826785A1 Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants thereof and other members of the erbb/her family
10/10/2012EP2508611A1 Process for production of triprenyl phenol compounds
10/10/2012EP2508608A1 Method of treating neurodegenerative disease
10/10/2012EP2508607A1 Medicament for liver regeneration and for treatment of liver failure
10/10/2012EP2508606A1 Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing the same
10/10/2012EP2508528A1 Stereoselective synthesis of beta-nucleosides
10/10/2012EP2508526A1 Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators
10/10/2012EP2508525A1 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
10/10/2012EP2508524A2 Indole compound
10/10/2012EP2508523A2 Polymorphs of dasatinib and process for preparation thereof
10/10/2012EP2508522A1 Azilsartan organic amine salts, preparation method and use thereof
10/10/2012EP2508521A2 Method for the production of amino crotonyl compounds
10/10/2012EP2508520A1 Pyrazolone-derivatives as PDE4 inhibitors
1 ... 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 ... 7860